Skip to main content
Erschienen in: Clinical Drug Investigation 7/2007

01.07.2007 | Case Report

Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin

verfasst von: Dr Sule Unal, Benan Bayrakci, Umit Yasar, Tevfik Karagoz

Erschienen in: Clinical Drug Investigation | Ausgabe 7/2007

Einloggen, um Zugang zu erhalten

Abstract

We report here the successful treatment of a 16-year-old female who ingested 20 tablets of digoxin each containing 0.25mg (total dose ingested equivalent to 0.1 mg/kg), 32 tablets of warfarin each containing 5mg (equivalent to 3.2 mg/kg), and approximately 15 tablets of propafenone each containing 300mg (equivalent to 90 mg/kg). The patient developed hypotension and sinus bradycardia necessitating external cardiac pacing 17 hours after drug ingestion. In addition to gastric lavage, activated charcoal, blood alkalinisation, administration of vitamin K and temporary cardiac pacing, the authors performed plasma exchange for drug removal and administered rifampicin in order to increase the metabolism of digoxin, propafenone and warfarin. The patient was discharged without any sequelae. Plasma exchange may be lifesaving in drug ingestions where there is a low volume of distribution and high plasma protein binding. Rifampicin, an inducer of cytochrome p450, may be used in intoxications for elimination of drugs with inactive metabolites.
Literatur
1.
Zurück zum Zitat Smith JW, Weinstein R. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003; 43: 820–2PubMedCrossRef Smith JW, Weinstein R. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis. Transfusion 2003; 43: 820–2PubMedCrossRef
2.
Zurück zum Zitat Klemmel PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003; 42: 1149–53CrossRef Klemmel PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis. Am J Kidney Dis 2003; 42: 1149–53CrossRef
3.
Zurück zum Zitat Lennertz A, Parhofer KG, Samtleben W, et al. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999; 3: 227–33PubMedCrossRef Lennertz A, Parhofer KG, Samtleben W, et al. Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis. Ther Apher 1999; 3: 227–33PubMedCrossRef
4.
Zurück zum Zitat Bosch T, Buhmann R, Lennertz A, et al. Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation. Ther Apher 1999; 3: 252–6PubMedCrossRef Bosch T, Buhmann R, Lennertz A, et al. Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation. Ther Apher 1999; 3: 252–6PubMedCrossRef
5.
Zurück zum Zitat Furlan M, Lammle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112–4PubMedCrossRef Furlan M, Lammle B. Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura: new insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112–4PubMedCrossRef
6.
Zurück zum Zitat Dau PC, Lindstrom JM, Cassel CK, et al. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977; 297: 1134–40PubMedCrossRef Dau PC, Lindstrom JM, Cassel CK, et al. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977; 297: 1134–40PubMedCrossRef
7.
Zurück zum Zitat Samtleben W, Mistry-Burchardi N, Hartmann B, et al. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001; 5: 351–7PubMedCrossRef Samtleben W, Mistry-Burchardi N, Hartmann B, et al. Therapeutic plasma exchange in the intensive care setting. Ther Apher 2001; 5: 351–7PubMedCrossRef
10.
Zurück zum Zitat Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001; 13: 91–7CrossRef Cruickshank J, Ragg M, Eddey D. Warfarin toxicity in the emergency department: recommendations for management. Emerg Med (Fremantle) 2001; 13: 91–7CrossRef
11.
Zurück zum Zitat Andiran N, Sarikayalar F. Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years? Turk J Pediatr 2004; 46: 147–2PubMed Andiran N, Sarikayalar F. Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years? Turk J Pediatr 2004; 46: 147–2PubMed
12.
Zurück zum Zitat Calvo MV, Martin-Suarez A, Martin Luengo C, et al. Interaction between digoxin and propafenone. Ther Drug Monit 1989; 11: 10–5PubMedCrossRef Calvo MV, Martin-Suarez A, Martin Luengo C, et al. Interaction between digoxin and propafenone. Ther Drug Monit 1989; 11: 10–5PubMedCrossRef
13.
Zurück zum Zitat Bigot MC, Debruyne D, Bonnefoy L, et al. Serum digoxin levels related to plasma propafenone levels during concomitant treatment. J Clin Pharmacol 1991; 31: 521–6PubMed Bigot MC, Debruyne D, Bonnefoy L, et al. Serum digoxin levels related to plasma propafenone levels during concomitant treatment. J Clin Pharmacol 1991; 31: 521–6PubMed
14.
Zurück zum Zitat Kates RE, Yee YG, Kirsten EB. Interaction between warfarin and propafenone in healthy volunteer subjects. Clin Pharmacol Ther 1987; 42: 305–11PubMedCrossRef Kates RE, Yee YG, Kirsten EB. Interaction between warfarin and propafenone in healthy volunteer subjects. Clin Pharmacol Ther 1987; 42: 305–11PubMedCrossRef
15.
Zurück zum Zitat Sketris IS, Parker WA, Jones JV. Effect of plasma exchange on drug removal. In: Valbonesi M, Pineda AA, Biggs JC, editors. Therapeutic hemapheresis. Milan, Italy: Wichtig Editore, 1986: 15–20 Sketris IS, Parker WA, Jones JV. Effect of plasma exchange on drug removal. In: Valbonesi M, Pineda AA, Biggs JC, editors. Therapeutic hemapheresis. Milan, Italy: Wichtig Editore, 1986: 15–20
16.
Zurück zum Zitat Zdunek M, Mitra A, Mokrzycki MH. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis 2000; 36: 177–83PubMedCrossRef Zdunek M, Mitra A, Mokrzycki MH. Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance. Am J Kidney Dis 2000; 36: 177–83PubMedCrossRef
17.
Zurück zum Zitat Henze T, Prange HW, Talartschik J, et al. Complications of plasma exchange in patients with neurological diseases. Klin Wochenschr 1990; 68: 1183–8PubMedCrossRef Henze T, Prange HW, Talartschik J, et al. Complications of plasma exchange in patients with neurological diseases. Klin Wochenschr 1990; 68: 1183–8PubMedCrossRef
18.
Zurück zum Zitat Harder S, Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet 1996; 30: 416–44PubMedCrossRef Harder S, Thurmann P. Clinically important drug interactions with anticoagulants: an update. Clin Pharmacokinet 1996; 30: 416–44PubMedCrossRef
19.
Zurück zum Zitat Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819–50PubMedCrossRef Niemi M, Backman JT, Fromm MF, et al. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42: 819–50PubMedCrossRef
20.
Zurück zum Zitat Yamamoto T, Suzuki A, Kohno Y. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes. Xenobiotica 2003; 33: 823–39PubMedCrossRef Yamamoto T, Suzuki A, Kohno Y. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes. Xenobiotica 2003; 33: 823–39PubMedCrossRef
Metadaten
Titel
Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin
verfasst von
Dr Sule Unal
Benan Bayrakci
Umit Yasar
Tevfik Karagoz
Publikationsdatum
01.07.2007
Verlag
Springer International Publishing
Erschienen in
Clinical Drug Investigation / Ausgabe 7/2007
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI
https://doi.org/10.2165/00044011-200727070-00008

Weitere Artikel der Ausgabe 7/2007

Clinical Drug Investigation 7/2007 Zur Ausgabe